BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10891654)

  • 21. A new small temperate DNA phage BcP15 isolated from Burkholderia cepacia DR11.
    Hens DK; Ghosh AN; Kumar R
    Arch Virol; 2005 Dec; 150(12):2421-8. PubMed ID: 16052281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of restriction fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex.
    Vermis K; Vandekerckhove C; Nelis HJ; Vandamme PA
    FEMS Microbiol Lett; 2002 Aug; 214(1):1-5. PubMed ID: 12204364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.
    Vandamme P; Henry D; Coenye T; Nzula S; Vancanneyt M; LiPuma JJ; Speert DP; Govan JR; Mahenthiralingam E
    FEMS Immunol Med Microbiol; 2002 Jun; 33(2):143-9. PubMed ID: 12052570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriophage phi297--the new species of temperate phages Pseudomonas aeruginosa with a mosaic genome: potential use in phagotherapy].
    Burkal'tseva MV; Krylov SV; Kropinskiĭ AM; Pletneva EA; Shaburova OV; Krylov VN
    Genetika; 2011 Jul; 47(7):900-4. PubMed ID: 21938953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transducing activity of the temperate SM bacteriophage of Pseudomonas aeruginosa].
    Gorelyshev AS; Tsygankov IuD; Kul'ba AM
    Genetika; 1984 Jan; 20(1):185-6. PubMed ID: 6421656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequencing of the Pseudomonas aeruginosa and Burkholderia cepacia genomes and their applications in relation to cystic fibrosis.
    Miller DA; Mahenthiralingam E
    J R Soc Med; 2003; 96 Suppl 43(Suppl 43):57-65. PubMed ID: 12906327
    [No Abstract]   [Full Text] [Related]  

  • 28. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.
    Agodi A; Mahenthiralingam E; Barchitta M; Gianninò V; Sciacca A; Stefani S
    J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a bacteriophage with broad host range against strains of Pseudomonas aeruginosa isolated from domestic animals.
    de Melo ACC; da Mata Gomes A; Melo FL; Ardisson-Araújo DMP; de Vargas APC; Ely VL; Kitajima EW; Ribeiro BM; Wolff JLC
    BMC Microbiol; 2019 Jun; 19(1):134. PubMed ID: 31208333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.
    Lynch KH; Dennis JJ
    Can J Microbiol; 2012 Mar; 58(3):221-35. PubMed ID: 22339239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and Transcriptional Mapping of PaMx41, Archetype of a New Lineage of Bacteriophages Infecting Pseudomonas aeruginosa.
    Cruz-Plancarte I; Cazares A; Guarneros G
    Appl Environ Microbiol; 2016 Nov; 82(22):6541-6547. PubMed ID: 27590812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudolysogeny of Pseudomonas aeruginosa bacteria infected with phiKZ-like bacteriophages].
    Pletnev EA; Krylov SV; Shaburova OV; Burkal'tseva MV; Miroshnikov KA; Krylov VN
    Genetika; 2010 Jan; 46(1):26-32. PubMed ID: 20198876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
    Vandamme P; Holmes B; Vancanneyt M; Coenye T; Hoste B; Coopman R; Revets H; Lauwers S; Gillis M; Kersters K; Govan JR
    Int J Syst Bacteriol; 1997 Oct; 47(4):1188-200. PubMed ID: 9336927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological and biological relationship among flagellin of Pseudomonas aeruginosa, Burkholderia cepacia and Stenotrophomonas maltophilia.
    Zgair AK; Chhibber S
    Mikrobiologiia; 2012; 81(3):371-6. PubMed ID: 22880399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISOLATION AND PRELIMINARY CHARACTERISTICS OF THREE BACTERIOPHAGES ASSOCIATED WITH A LYSOGENIC STRAIN OF PSEUDOMONAS AERUGINOSA.
    FEARY TW; FISHER E; FISHER TN
    J Bacteriol; 1964 Jan; 87(1):196-208. PubMed ID: 14102854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriocins and bacteriophages of pathogenic Burkholderia].
    Iliukhin VI; Merinova LK; Ageeva NP; Senina TV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):12-9. PubMed ID: 21446163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of Pseudomonas aeruginosa transposable phages in Pseudomonas putida cells. I. The establishment of a lysogenic state and the effectiveness of lytic development].
    Gorbunova SA; Ianenko AS; Akhverdian VZ; Reulets MA; Krylov VN
    Genetika; 1985 Sep; 21(9):1455-63. PubMed ID: 2998927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.